✦ LIBER ✦

Epstein-Barr virus and cancers of the head and neck

✍ Scribed by David Goldenberg; Avishay Golz; Aviram Netzer; Edward Rosenblatt; Adi Rachmiel; Renee Flax Goldenberg; Henry Zvi Joachims

Book ID: 117815024
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 97 KB
Volume: 22
Category: Article
ISSN: 1532-818X
DOI: 10.1053/ajot.2001.23429

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association of p53 and BCL-2 expression

Association of p53 and BCL-2 expression with Epstein-Barr virus infection in the cancers of head and neck

✍ Hui Jun Yang; Young Jun Cho; Hee Sung Kim; Mee Soo Chang; Myung-Whun Sung; Woo H 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 608 KB

## Background: Reports that have both evaluated the site-specific epstein-barr virus (ebv) infection and compared it with the expression of the ebv-related proto-oncogenes and tumor suppressor genes in the various cancers of head and neck are scarce. ## Methods: Thirty-eight nasopharyngeal carcin

Epstein-Barr virus (EBV) associated lesi

Epstein-Barr virus (EBV) associated lesions of the head and neck

✍ A Boulter; NW Johnson; W Birnbaum; CG Teo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 918 KB

Epstein-barr virus-specific serodiagnost

Epstein-barr virus-specific serodiagnostic tests in carcinomas of the head and neck

✍ Ulrik Ringborg; Werner Henle; Gertrude Henle; Snorri Ingimarsson; George Klein; 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 633 KB

Epstein-Barr Virus and Cancer

✍ Thompson, M. P. 📂 Article 📅 2004 🏛 American Association for Cancer Research 🌐 English ⚖ 317 KB

Epstein-barr virus (EBV) antibody in pat

Epstein-barr virus (EBV) antibody in patients treated by radical radiotherapy for head and neck cancer

✍ Marlene R. Halili; Ilya Spigland; Nan Foster; Nemetallah A. Ghossein 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB

Antibody against Epstein Barr Viral capsid (EBV-VCA) was measured in 65 patients with primary head and neck cancer referred for radical radiotherapy. Sixty-three percent had locally advanced cancer and 37% had early disease. Forty-eight percent had detectable antibody in their sera. Thirty-three per

Epstein-barr virus and esophageal cancer

✍ Stoecklein, N.H.; Hosch, S.B.; Izbicki, J.R.; Herbst, H. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 170 KB